OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data

<p>Trigeminal neuralgia (TN) patients may develop side effects from centrally acting drugs, have contraindications for neurosurgical procedures, or experience relapse during conventional therapies. OnabotulinumtoxinA (BoNT/A) has been reported to be effective for TN, although this finding has...

Full description

Saved in:
Bibliographic Details
Main Authors: Pedro A. Kowacs, Marco A. T. Utiumi, Fábio A. Nascimento, Elcio J. Piovesan, Helio A. G. Teive
Format: Article
Language:English
Published: Thieme Revinter Publicações 2015-01-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015005050109&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!